Meditor Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-55,100
Closed -$3.98M 6
2013
Q3
$3.98M Buy
+55,100
New +$3.98M 0.56% 26